OTCMKTS:CDXI Cardax (CDXI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About Cardax Stock (OTCMKTS:CDXI) Get Cardax alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cardax, Inc. (OTCMKTS:CDXI) is a clinical-stage biotechnology company focused on the discovery and development of novel anti-inflammatory drug candidates. The company’s proprietary platform utilizes phospholipid-conjugated formulations of astaxanthin designed to enhance bioavailability and target chronic inflammatory and fibrotic conditions. Cardax’s lead program, CARD-024, is advancing in preclinical development for the treatment of atherosclerosis and related cardiovascular diseases. In addition to its cardiovascular pipeline, the company is exploring immuno-oncology and gastrointestinal indications, leveraging its core technology to create differentiated therapeutic assets across multiple disease areas. Headquartered in Honolulu, Hawaii, Cardax conducts its research and development activities primarily within the United States. The management team combines expertise in pharmaceutical sciences, clinical operations and regulatory affairs, positioning the company to progress its candidates through critical preclinical and early clinical milestones.AI Generated. May Contain Errors. Read More Receive CDXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardax and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDXI Stock News HeadlinesCardax Inc.December 14, 2025 | wsj.comCardiometabolic Disease Market Size Worth USD 868.45 Billion by 2032 at 24% CAGR – Report by Market Research Future (MRFR)June 2, 2023 | finance.yahoo.comA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, and predictions. He argues a simpler approach can work just as well. His free report, The Simple Path To Success With Options, breaks down a repeatable trade setup, common rookie mistakes, and step-by-step blueprints designed to cut through market noise. No complex charts. No guesswork. Just a straightforward setup anyone can learn. | TradeWins (Ad)CDXI.PK - Cardax Inc | Stock Price & Latest News | ReutersOctober 10, 2022 | reuters.comCardax, Inc. (CDXI)October 4, 2022 | finance.yahoo.comCDXI After-Hours QuotesJanuary 20, 2022 | nasdaq.comCardax Inc. makes several moves to reduce costsSeptember 2, 2021 | news.yahoo.comCardax Refocuses on ZanthoSyn® Consumer Health BusinessAugust 31, 2021 | finance.yahoo.comSee More Headlines CDXI Stock Analysis - Frequently Asked Questions How do I buy shares of Cardax? Shares of CDXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cardax own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardax investors own include Ashford Hospitality Trust (AHT), Peabody Energy (BTU), Assertio (ASRT), Astronics (ATRO), Alliance Resource Partners (ARLP). Company Calendar Today9/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:CDXI CIK1544238 Webwww.cardaxpharma.com Phone(808) 457-1400Fax808-237-5901Employees10Year Founded2006Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares800,000Free Float566,000Market CapN/A OptionableNot Optionable BetaN/A Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:CDXI) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredPrint this before your next tradeBill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97. It'...Profits Run | SponsoredElon Musk to Trigger Next AI Wave on November 11th?Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsoredyour job is on the listThe CEO of one of the largest AI labs on earth said it plainly: AI could wipe out half of all entry-level whit...Behind the Markets | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardax With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDXI Stock Alerts